Healthcare News Papua New Guinea: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare News Papua New Guinea.

Press releases published on October 15, 2026

5 hours ago

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

Indeterminate GlobeNewswire

5 hours ago

Why Is Weight Loss Different During Menopause? Common Myths Debunked

Indeterminate GlobeNewswire

5 hours ago

Ligand to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

5 hours ago

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Europe 2026

Indeterminate GlobeNewswire

5 hours ago

Eclipse Life Sciences Announces Positive Topline Results from Phase 2 BETTIS-1 Study Evaluating EC-104 for Diabetic Macular Edema (DME)

Indeterminate GlobeNewswire

5 hours ago

Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab

Indeterminate GlobeNewswire

5 hours ago

Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome

Indeterminate GlobeNewswire

5 hours ago

Rethink s’associe à Joe Fresh(MC) et à la Fondation Pharmaprix pour la santé des femmes(MC)

Indeterminate GlobeNewswire

5 hours ago

Rethink Partners with Joe Fresh™ & Shoppers Foundation for Women's Health™

Indeterminate GlobeNewswire

5 hours ago

SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia

Indeterminate GlobeNewswire

5 hours ago

Seres Therapeutics to Present Preclinical Data for SER-428, an Investigational Live Biotherapeutic Designed to Reduce Risk of Bloodstream Infections in Critically Ill Patients, at IDWeek 2026

Indeterminate GlobeNewswire

5 hours ago

Aquestive Therapeutics Announces FDA Acceptance of Anaphylm™ NDA Resubmission and PDUFA Goal Date of March 16, 2027

Indeterminate GlobeNewswire

5 hours ago

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Indeterminate GlobeNewswire

5 hours ago

Cronos Completes Acquisition of CanAdelaar, Europe’s Largest Adult-Use Cannabis Company

Indeterminate GlobeNewswire

5 hours ago

Cellectar Biosciences Presents Compelling Efficacy Data from Phase 2b CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Relapsed/Refractory to BTK Inhibitor Therapy at the International Workshop for Waldenström Macroglobulinemia

Indeterminate GlobeNewswire

6 hours ago

Profusa Receives ISO 13485:2016 Certificate from GMED

Indeterminate GlobeNewswire

6 hours ago

Affidea signs agreement to acquire two Alliance Medical centres in central London, accelerating its UK growth

Indeterminate GlobeNewswire

6 hours ago

Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

7 hours ago

Osivax Reports Phase 2b Results for OVX836 and Advances Combination Strategy for Next-Generation Seasonal Influenza Vaccines

Indeterminate GlobeNewswire

8 hours ago

EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe

Indeterminate GlobeNewswire